Green Organic Dutchman Holdings Ltd
Green Organic Dutchman’s Losses Narrow as Revenue Rises in Q1
Green Organic Dutchman Holdings (TGOD) (TGODF) reported its first-quarter earnings yesterday after the markets closed.
How Analysts View Cresco Labs before Its Q1 Release
Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.
Cannabis Stocks Had a Mixed Performance Last Week
Cannabis ETFs traded on a largely negative note last week.
Acreage: Analysts Lower Targets after Q3 Earnings
Acreage Holdings (ACRG)(ACRGF) reported its third-quarter earnings after markets closed on November 12. Here’s how analysts have reacted since.
Comparing GW Pharmaceuticals’ Returns to Peers
GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.
Why Are Canadian Cannabis Companies Leaving Jamaica?
Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.
Cannabis Sector Rounds Out the Week in the Green
Yesterday, Ontario’s government announced that it was scrapping its cap on the number of private retail cannabis stores and moving toward a new system.
Ontario Cannabis Retail: A Much-Needed Update
As reported by BNN Bloomberg on December 6, Ontario Cannabis Store interim CEO Cal Bricker is confident in Ontario’s readiness for the Cannabis 2.0 launch.
Why Cannabis Stocks Are Trending Down Today
Today, the cannabis sector was trading in the red despite the broader US equity market trading in the green. Here’s what’s going on.
Why the Cannabis Sector Continued to Slide Today
This week has been tough for the cannabis sector. Cronos Group and Canopy Growth reported lower-than-expected earnings, and the sector ETFs dropped.
Curaleaf Launches Adult-Use Cannabis in MA
Yesterday, Curaleaf Holdings (CURLF) (CURA) opened its first recreational or adult-use dispensary in Massachusetts at Oxford.
Cannabis Stocks: Canaccord Updates Target Prices
For Aurora Cannabis (ACB), Canaccord lowered its target price from 13.50 Canadian dollars to 8.00 Canadian dollars with a “speculative buy” rating.
Aurora Cannabis Stock: What Options Traders Expect
We discuss Aurora Cannabis’s price target cut as well as recent options trades—and what ACB investors can expect from the stock this week.
Cannabis Stocks Down Today alongside Juul Announcement
Today, the cannabis sector was down alongside the broader US equity market. Take a look at the cannabis stocks and ETFs’ and Juul’s big announcement.
Cannabis Roundup: MMEN, APHA, ACB, and TGOD
The US markets rose on optimism surrounding US-China trade talks. However, weakness in the cannabis sector led the cannabis ETFs trading in the red.
Will Cannabis Stocks Bleed More? MKM Weighs In
This year, the cannabis sector has been underperforming the broader equity market. Will cannabis stocks bleed more after MKM Partners’ bearish outlook?
Cannabis Roundup: ACB, TGOD, CURA, and APHA
At 1:40 PM ET, the S&P 500 Index was up 0.6%. However, the cannabis ETFs fell, led by Aurora Cannabis’s weak fourth-quarter earnings results.
Cannabis Roundup: ACB, TLRY, CRON, and OGI
The S&P 500 Index and the DJIA fell 0.3% and 0.1%, respectively, today. However, the cannabis ETFs and the majority of the cannabis stocks were trading in the green.
Aphria versus Aurora Cannabis: A Valuation Update
On September 6, Aurora Cannabis and Aphria were trading at a higher forward EV-to-sales multiple than their peers’ median value of 12.26.
Cannabis Roundup: WEED, ACB, ACRGF, and CTST
News that the US and China plan to revive trade talks in October boosted the US stock market. Most of the cannabis players traded in the green today.
Key Cannabis Sector Updates: Analyst Ratings and Earnings
Last week, Emerald Health Therapeutics (EMH) closed with losses of 9.4%.